Physician profile
John D Serini
NPI 1285679589
$1,586.01
in general payments reported to CMS, 2019-2025
11 companies · $26.37 in 2025
The $26.37 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $164 · 2021: $170 · 2022: $342 · 2023: $361 · 2024: $72.19 · 2025: $26.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $569.75 | 2019-2024 | Skyrizi, Rinvoq, Linzess |
| Janssen Biotech, INC. | $511.76 | 2019-2023 | Simponi, Simponi Aria, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $231.74 | 2019-2025 | Entyvio |
| Pfizer INC. | $63.84 | 2019-2021 | |
| Shionogi INC | $49.87 | 2019-2020 | |
| Braintree Laboratories, INC. | $35.76 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.26 | 2019 | |
| Celgene Corporation | $32.35 | 2021-2023 | Zeposia |
| Ucb, INC. | $26.41 | 2019 | |
| W. L. Gore & Associates, INC. | $14.74 | 2023 | Gore Cardioform Septal Occluder |
| Genzyme Corporation | $14.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Serini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.